Abstract
Purpose
Stress and anxiety are potential consequences from arrhythmias and implantable cardioverter defibrillator (ICD) shocks that can contribute to substantial morbidity. We assessed anxiety associated with an ICD and whether cognitive behavioral therapy (CBT) reduces anxiety.
Methods
The study consisted of two parts: part 1 (N = 690) was a prospective cross-sectional observational study of consecutive ICD patients. Patients completed the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder Scale (GAD-7), Florida Shock Anxiety Scale (FSAS), and Florida Patient Acceptance Survey (FPAS) psychometric tests. Part 2 (N = 29) was a pilot randomized controlled trial of CBT (three sessions in 3 months) vs. usual care (UC) in patients with BAI ≥ 19 from part 1.
Results
The median BAI and GAD-7 scores were 5 and 2, respectively. By BAI scores, 64.5 % had minimal and 3.9 % had severe anxiety. By GAD-7 scores, 73.0 % had low probability of anxiety and 2.9 % had high anxiety. Higher anxiety levels were associated with recent (p = 0.017) and total number of shocks (p = 0.002). Any shock was associated with fear about shocks (FSAS, p < 0.001) and reduced patient ICD acceptance (FPAS, p = 0.019). In the pilot trial of CBT, median BAI scores decreased from 24.5 to 11 at 1 year (p = 0.031) in the CBT group and GAD-7 scores from 12.5 to 7 (p = 0.063); no significant changes in anxiety scores were observed in the UC group.
Conclusions
Severe anxiety was present in a small proportion of ICD patients, but higher anxiety was associated with recent and total number of shocks. The small pilot study suggested that a simple program of CBT might lower moderate-high anxiety with lasting effects to 1 year and supports the need for a larger trial to validate these results.
Clinical Trial Registration: ClinicalTrials.gov identifier: NCT00851071.
URL: http://clinicaltrials.gov/ct2/show/NCT00851071?term=anxiety+in+icd+patients+cleveland+clinic&rank=1
Similar content being viewed by others
Abbreviations
- CBT:
-
Cognitive behavioral therapy
- UC:
-
Usual care
- ICD:
-
Implantable cardioverter defibrillator
References
Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. New England Journal of Medicine, 359(10), 1009–1017.
Schluter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47(3), 459–463.
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237.
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–1890.
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997). New England Journal of Medicine, 337(22), 1576–1583.
Hallas, C. N., Burke, J. L., White, D. G., & Connelly, D. T. (2010). A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery. Circulation. Arrhythmia and Electrophysiology, 3(2), 170–177.
van den Broek, K. C., Nyklicek, I., & Denollet, J. (2009). Anxiety predicts poor perceived health in patients with an implantable defibrillator. Psychosomatics, 50(5), 483–492.
Sears, S. F., Jr., Todaro, J. F., Lewis, T. S., Sotile, W., & Conti, J. B. (1999). Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clinical Cardiology, 22(7), 481–489.
Bilge, A. K., Ozben, B., Demircan, S., Cinar, M., Yilmaz, E., & Adalet, K. (2006). Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing and Clinical Electrophysiology, 29(6), 619–626.
Burg, M. M., Lampert, R., Joska, T., Batsford, W., & Jain, D. (2004). Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosomatic Medicine, 66(6), 898–902.
Lampert, R., Joska, T., Burg, M. M., Batsford, W. P., McPherson, C. A., & Jain, D. (2002). Emotional and physical precipitants of ventricular arrhythmia. Circulation, 106(14), 1800–1805.
Hegel, M. T., Griegel, L. E., Black, C., Goulden, L., & Ozahowski, T. (1997). Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. International Journal of Psychiatry in Medicine, 27(1), 57–69.
Aronow, W. S. (2010). Use of implantable cardioverter-defibrillators. Future Cardiology, 6(6), 859–870.
Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K. H., Zipes, D. P., et al. (2000). Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. European Heart Journal, 21(24), 2071–2078.
Ingles, J., Sarina, T., Kasparian, N., & Semsarian, C. (2013). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology. 168(4), 3779–3784.
Freedenberg, V., Thomas, S. A., & Friedmann, E. (2011). Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Failure Clinic, 7(1), 59–68.
Chevalier, P., Cottraux, J., Mollard, E., Sai, N., Brun, S., Burri, H., et al. (2006). Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. American Heart Journal, 151(1), 191.
Fitchet, A., Doherty, P. J., Bundy, C., Bell, W., Fitzpatrick, A. P., & Garratt, C. J. (2003). Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart, 89(2), 155–160.
Lewin, R. J., Coulton, S., Frizelle, D. J., Kaye, G., & Cox, H. (2009). A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart, 95(1), 63–69.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.
Julian, L. J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Research (Hoboken), 63(Suppl 11), S467–S472.
Kertz, S., Bigda-Peyton, J., & Bjorgvinsson, T. (2012). Validity of the Generalized Anxiety Disorder-7 Scale in an Acute Psychiatric Sample. Clinical Psychology & Psychotherapy. 20(5), 456–464.
Kuhl, E. A., Dixit, N. K., Walker, R. L., Conti, J. B., & Sears, S. F. (2006). Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology, 29(6), 614–618.
Burns, J. L., Serber, E. R., Keim, S., & Sears, S. F. (2005). Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. Journal of Cardiovascular Electrophysiology, 16(4), 384–390.
Habibovic, M., Versteeg, H., Pelle, A. J., Theuns, D. A., Jordaens, L., & Pedersen, S. S. (2013). Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace, 15(3), 355–361.
Magyar-Russell, G., Thombs, B. D., Cai, J. X., Baveja, T., Kuhl, E. A., Singh, P. P., et al. (2011). The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. Journal of Psychosomatic Research, 71(4), 223–231.
Godemann, F., Butter, C., Lampe, F., Linden, M., Schlegl, M., Schultheiss, H. P., et al. (2004). Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clinical Cardiology, 27(6), 321–326.
Jacq, F., Foulldrin, G., Savoure, A., Anselme, F., Baguelin-Pinaud, A., Cribier, A., et al. (2009). A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. General Hospital Psychiatry, 31(3), 266–273.
Van den Broek, K. C., Nyklicek, I., Van der Voort, P. H., Alings, M., & Denollet, J. (2008). Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing and Clinical Electrophysiology, 31(7), 850–857.
Chevalier, P., Verrier, P., Kirkorian, G., Touboul, P., & Cottraux, J. (1996). Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator: a psychometric study. Psychotherapy and Psychosomatics, 65(1), 49–56.
Dunbar, S. B., Langberg, J. J., Reilly, C. M., Viswanathan, B., McCarty, F., Culler, S. D., et al. (2009). Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing and Clinical Electrophysiology, 32(10), 1259–1271.
Redhead, A. P., Turkington, D., Rao, S., Tynan, M. M., & Bourke, J. P. (2010). Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research, 69(6), 555–563.
Pedersen, S. S., Sears, S. F., Burg, M. M., & Van Den Broek, K. C. (2009). Does ICD indication affect quality of life and levels of distress? Pacing and Clinical Electrophysiology, 32(2), 153–156.
Sears, S. F., Sowell, L. D., Kuhl, E. A., Kovacs, A. H., Serber, E. R., Handberg, E., et al. (2007). The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing and Clinical Electrophysiology, 30(7), 858–864.
Funding source
The study was supported by a grant from the Cleveland Clinic Bakken Heart Brain Institute. M. Chung has received support from NIH R01 HL111314 and R01 HL090620.
Relationships with industry
M. Chung: industry-sponsored research with Medtronic, Boston Scientific, St. Jude Medical, Biotronik. S. Sears: consultant to Medtronic; are search grants from Medtronic directed to East Carolina University; speaker honorarium from Medtronic, Boston Scientific, St Jude Medical, Biotronik; founder of QOL Apps, Inc. and inventor of ICD Coach. S. Pedersen consultant for Boston Scientific. All other authors disclose no relationships with industry.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mohammed Qintar and Jason J. George equal first authors.
Rights and permissions
About this article
Cite this article
Qintar, M., George, J.J., Panko, M. et al. A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. J Interv Card Electrophysiol 43, 65–75 (2015). https://doi.org/10.1007/s10840-015-9990-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-015-9990-7